Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BHST NASDAQ:BYSI NASDAQ:HYFT NASDAQ:PASG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHSTBioHarvest Sciences$3.26$3.87$3.02▼$12.80$63.95M0.721,771 shs2,179 shsBYSIBeyondSpring$1.61$1.60$1.18▼$3.28$66.20M0.4323,057 shs35,146 shsHYFTMindWalk$1.53$1.43$0.82▼$3.25$70.62M0.79471,360 shs269,508 shsPASGPassage Bio$5.59$6.21$3.93▼$20.00$17.93M1.4137,869 shs73,067 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHSTBioHarvest Sciences-0.61%+1.87%-16.84%-23.65%-53.09%BYSIBeyondSpring+1.26%-2.42%+24.81%+0.63%-48.23%HYFTMindWalk+2.00%-6.71%+21.43%+31.90%+152,999,900.00%PASGPassage Bio+4.88%-0.18%+10.04%-24.76%-28.43%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHSTBioHarvest Sciences$3.26$3.87$3.02▼$12.80$63.95M0.721,771 shs2,179 shsBYSIBeyondSpring$1.61$1.60$1.18▼$3.28$66.20M0.4323,057 shs35,146 shsHYFTMindWalk$1.53$1.43$0.82▼$3.25$70.62M0.79471,360 shs269,508 shsPASGPassage Bio$5.59$6.21$3.93▼$20.00$17.93M1.4137,869 shs73,067 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHSTBioHarvest Sciences-0.61%+1.87%-16.84%-23.65%-53.09%BYSIBeyondSpring+1.26%-2.42%+24.81%+0.63%-48.23%HYFTMindWalk+2.00%-6.71%+21.43%+31.90%+152,999,900.00%PASGPassage Bio+4.88%-0.18%+10.04%-24.76%-28.43%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBHSTBioHarvest Sciences 2.00Hold$10.00206.75% UpsideBYSIBeyondSpring 1.00SellN/AN/AHYFTMindWalk 2.60Moderate Buy$5.00226.80% UpsidePASGPassage Bio 2.11Hold$13.25137.03% UpsideCurrent Analyst Ratings BreakdownLatest PASG, HYFT, BHST, and BYSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2026BHSTBioHarvest Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/10/2026PASGPassage Bio UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral6/10/2026PASGPassage Bio GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral6/3/2026BHSTBioHarvest Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/19/2026HYFTMindWalk HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/21/2026PASGPassage Bio Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy ➝ Neutral$21.00 ➝ $7.004/21/2026PASGPassage Bio Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$21.00 ➝ $7.004/21/2026PASGPassage Bio OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$30.00 ➝ $15.004/21/2026PASGPassage Bio TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold4/21/2026PASGPassage Bio WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$32.00 ➝ $8.004/20/2026PASGPassage Bio WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageReduce(Data available from 6/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBHSTBioHarvest Sciences$34.51M1.85N/AN/A$1.30 per share2.51BYSIBeyondSpring$1.75M37.83$0.11 per share14.17($0.59) per share-2.73HYFTMindWalk$17.59M4.02N/AN/A$0.37 per share4.14PASGPassage BioN/AN/AN/AN/A$5.90 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBHSTBioHarvest Sciences-$11.14M-$0.59N/AN/AN/A-32.54%-76.03%-25.30%8/10/2026 (Estimated)BYSIBeyondSpring-$1.01M-$0.14N/AN/AN/AN/AN/A-14.00%8/12/2026 (Estimated)HYFTMindWalk-$21.69M-$0.20N/AN/AN/A-66.79%-69.37%-39.74%N/APASGPassage Bio-$45.52M-$11.84N/AN/AN/AN/A-150.88%-59.78%7/30/2026 (Estimated)Latest PASG, HYFT, BHST, and BYSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026BHSTBioHarvest Sciences-$0.13-$0.11+$0.02-$0.11$8.50 million$8.51 million5/13/2026Q4 2025BYSIBeyondSpring-$0.54-$0.05+$0.49-$0.05$8.77 millionN/A5/12/2026Q1 2026PASGPassage Bio-$2.7640-$2.36+$0.4040-$2.36N/AN/A4/1/2026Q4 2025BHSTBioHarvest Sciences-$0.11-$0.10+$0.01-$0.10$9.24 million$9.07 million3/25/2026Q4 2025BYSIBeyondSpring-$0.54-$0.05+$0.49-$0.05N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBHSTBioHarvest SciencesN/AN/AN/AN/AN/ABYSIBeyondSpringN/AN/AN/AN/AN/AHYFTMindWalkN/AN/AN/AN/AN/APASGPassage BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBHSTBioHarvest Sciences0.032.962.44BYSIBeyondSpringN/A1.091.09HYFTMindWalk0.213.743.64PASGPassage BioN/A1.731.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBHSTBioHarvest SciencesN/ABYSIBeyondSpring40.29%HYFTMindWalk6.70%PASGPassage Bio53.48%Insider OwnershipCompanyInsider OwnershipBHSTBioHarvest SciencesN/ABYSIBeyondSpring29.31%HYFTMindWalk6.83%PASGPassage Bio4.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBHSTBioHarvest SciencesN/A19.62 millionN/AN/ABYSIBeyondSpring8041.12 million29.07 millionOptionableHYFTMindWalk8046.16 million43.00 millionN/APASGPassage Bio1303.21 million3.05 millionNo DataPASG, HYFT, BHST, and BYSI HeadlinesRecent News About These CompaniesBrokerages Set Passage Bio, Inc. (NASDAQ:PASG) Target Price at $13.25June 13, 2026 | americanbankingnews.comPassage Bio (NASDAQ:PASG) Trading Down 2.7% - Time to Sell?June 9, 2026 | americanbankingnews.comPassage Bio, Inc. résilie son accord de collaboration de recherche avec Gemma Biotherapeutics, IncJune 3, 2026 | zonebourse.comZPassage Bio Ends Key Collaborations and Office LeaseMay 27, 2026 | tipranks.comPassage Bio Shareholders Approve Directors and Executive PayMay 26, 2026 | tipranks.comPassage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside?May 20, 2026 | finance.yahoo.comPassage Bio (PASG) price target decreased by 62.83% to 11.63April 28, 2026 | msn.comTD Cowen downgrades Passage Bio (PASG)April 23, 2026 | msn.comPassage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate UpdatesApril 20, 2026 | globenewswire.comPassage Bio (PASG) Gets a Buy from Chardan CapitalApril 8, 2026 | theglobeandmail.comOppenheimer initiates coverage of Passage Bio (PASG) with outperform recommendationApril 1, 2026 | msn.comPassage Bio (PASG) price target decreased by 22.22% to 31.42March 28, 2026 | msn.comPassage Bio advances frontotemporal dementia trial and reports 2025 resultsMarch 10, 2026 | msn.comPassage Bio Ends Hopewell Lab Lease, Extends Cash RunwayMarch 10, 2026 | tipranks.comAnalysts Are Bullish on These Healthcare Stocks: Esperion (ESPR), Passage Bio (PASG)March 8, 2026 | theglobeandmail.comPassage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business HighlightsMarch 3, 2026 | globenewswire.comPassage Bio management to present at two healthcare conferencesFebruary 24, 2026 | msn.comPassage Bio to Participate in Upcoming Investor ConferencesFebruary 19, 2026 | globenewswire.comPassage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in StockJanuary 13, 2026 | insidertrades.comFinancial Comparison: Passage Bio (NASDAQ:PASG) versus PepGen (NASDAQ:PEPG)December 7, 2025 | defenseworld.netDNew MarketBeat Followers Over TimeMedia Sentiment Over TimePASG, HYFT, BHST, and BYSI Company DescriptionsBioHarvest Sciences NASDAQ:BHST$3.26 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$3.29 +0.03 (+0.92%) As of 06/18/2026 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.BeyondSpring NASDAQ:BYSI$1.61 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.62 +0.01 (+0.93%) As of 06/18/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing Plinabulin in combination with docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy or radiation, including; nivolumab, a PD-1 antibody that is has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.MindWalk NASDAQ:HYFT$1.53 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.56 +0.03 (+1.90%) As of 06/18/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.Passage Bio NASDAQ:PASG$5.59 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$5.52 -0.06 (-1.16%) As of 06/18/2026 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate American Eagle’s Q1 Beat Leaves Investors With a Bigger Question Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
